Related Experiment Videos

No evidence of germline PTEN mutations in familial prostate cancer

M S Forrest, S M Edwards, R A Hamoudi

Journal of Medical Genetics

|April 25, 2000

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Seven or less Fractions is Not the Standard of Care for Intermediate-Risk Prostate Cancer.

Clinical oncology (Royal College of Radiologists (Great Britain))·2019

Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2019

Validation of T2- and diffusion-weighted magnetic resonance imaging for mapping intra-prostatic tumour prior to focal boost dose-escalation using intensity-modulated radiotherapy (IMRT).

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2019

Runs of homozygosity and testicular cancer risk.

Andrology·2019

Forward- and Inverse-Planned Intensity-Modulated Radiotherapy in the CHHiP Trial: A Comparison of Dosimetry and Normal Tissue Toxicity.

Clinical oncology (Royal College of Radiologists (Great Britain))·2019

Dosimetry and Gastrointestinal Toxicity Relationships in a Phase II Trial of Pelvic Lymph Node Radiotherapy in Advanced Localised Prostate Cancer.

Clinical oncology (Royal College of Radiologists (Great Britain))·2019

See all related articles